PAREXEL: Robust Growth + Low Valuation = Strong Buy [Seeking Alpha]
PAREXEL INTL (PRXL)
Last parexel intl earnings: 8/28 06:21 pm
Check Earnings Report
US:NASDAQ Investor Relations:
parexel.com/etc/ir
Company Research
Source: Seeking Alpha
Summary Business Overview Developing a new drug - from inception to approval - can take 10-15 years, sometimes as long as 20 years, and cost in excess of $2.5 billion . To speed up development and cut costs, drug makers are increasingly outsourcing their R&D to contract research organizations (CROs). One of the world's largest CROs and the topic of this report is PAREXEL (NASDAQ: PRXL ). PAREXEL's business model is quite simple. It helps drug makers maximize the return on their significant investment in R&D by reducing the time, risk, and cost of developing and launching new drugs. This business is divided into three segments: Clinical Research Services, or CRS, is the largest segment at 76% of revenue. It focuses on all phases of clinical research from first-in-human/Phase I trials all the way through post-approval/Phase IV studies. Barriers to entry here are high, particularly in the later-stage Phase III and IV arena. For instance, Phase III trials usually requi
Show less
Read more
Impact Snapshot
Event Time:
PRXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRXL alerts
High impacting PAREXEL INTL news events
Weekly update
A roundup of the hottest topics